There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.
Rebecca A. Falter, PharmD
Advertisement
Articles by Rebecca A. Falter, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Overcoming Barriers to Kidney-Protective Therapy
2
Night Shift Work, Chronic Insomnia Nearly Triple Long-COVID Risk, Study Finds
3
FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma
4
Why Blood Pressure Won't Budge—and How Pharmacists Help
5